Related Experiment Video
Updated: Jul 14, 2026
05:54
MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
Published on: December 13, 2017
Transient improvement of essential tremor during electroconvulsive therapy
Steven A Kushner1, Joan Prudic, Elan D Louis
1New York State Psychiatric Institute, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
The Journal of ECT
|June 6, 2007
Summary
Electroconvulsive therapy (ECT) temporarily improved essential tremor (ET) in a patient, matching medication efficacy. This novel observation offers insights into ET
Area of Science:
- Neurology
- Neuroscience
- Clinical Medicine
Background:
- Essential tremor (ET) is a common neurological disorder.
- Current treatments for ET offer variable efficacy and side effects.
- The pathophysiology of ET remains incompletely understood.
Observation:
- A patient with essential tremor (ET) experienced significant, transient symptom improvement during electroconvulsive therapy (ECT).
- The tremor reduction during ECT was comparable in magnitude to first-line ET medications.
- This improvement persisted throughout the ECT treatment course.
Findings:
- This case report is the first to document tremor improvement during ECT.
- The observation suggests a potential modulatory effect of ECT on ET symptoms.
- The findings warrant further investigation into the neurobiological underpinnings of ET.
Implications:
- This observation may offer new perspectives on ET pathophysiology.
- Exploring the mechanisms behind ECT's effect could reveal novel therapeutic targets for ET.
- Further research is needed to validate and understand this phenomenon in ET patients.
More Related Videos
Related Concept Videos
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...